Gastroenterology

Gastroenterology

Volume 113, Issue 5, November 1997, Pages 1623-1631
Gastroenterology

Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding

https://doi.org/10.1053/gast.1997.v113.pm9352865Get rights and content

Abstract

BACKGROUND & AIMS: In patients with cirrhosis of the liver, after the first variceal bleeding episode, transjugular intrahepatic portosystemic stent shunting (TIPS) and endoscopic sclerotherapy plus propranolol (ES) were compared regarding prevention of variceal rebleeding and mortality.

METHODS: Eighty-three patients with cirrhosis of the liver were randomized to undergo TIPS (n = 42) or ES (n = 41).

RESULTS: Median observation time was in 1.6 years in the TIPS group and 1.45 years in the ES group. Cumulative rates of rebleeding were 23% in the TIPS group and 57% in the ES group (P = 0.0001). Hepatic encephalopathy was observed in 29% of the patients in the TIPS group and in 13% of those in the ES group (P = 0.041). Cumulative rates of survival were 69% in the TIPS group and 67% in the ES group (P = 0.62). Mortality rates in both groups were positively correlated with a higher Child's classification.

CONCLUSIONS: Although TIPS significantly reduced the rate of rebleeding, survival rates were not improved. Because TIPS is associated with an increased risk of encephalopathy and high rates of shunt dysfunction, which requires reintervention, the procedure cannot be recommended for elective treatment after the first variceal bleeding episode, but it is an effective therapy in patients in whom endoscopic sclerotherapy fails to control bleeding.

(Gastroenterology 1997 Nov;113(5):1623-31)

References (0)

Cited by (169)

  • ACR Appropriateness Criteria® Radiologic Management of Portal Hypertension

    2021, Journal of the American College of Radiology
  • Contrast-enhanced ultrasound at high mechanical index: a new method for transjugular intrahepatic portosystemic shunt follow-up

    2020, Clinical Radiology
    Citation Excerpt :

    Transjugular intrahepatic portosystemic shunt (TIPS) is an effective and relatively safe approach for managing many complications of portal hypertension. It is an attractive option due to its high technical, clinical success rates1–3 and effectiveness in bleeding control.2,4–6 Moreover, TIPS has low morbidity and mortality and is associated with the eliminating ascites or substantially reducing ascites in cases that are refractory to medical therapy2,7; however, TIPS implantation is complicated by high re-intervention rates, which are mainly caused by thrombosis or stenosis of the stent and hepatic venous outflow tract.

  • Chapter 87 - Transjugular intrahepatic portosystemic shunting: Indications and technique

    2016, Blumgart's Surgery of the Liver, Biliary Tract and Pancreas: Sixth Edition
View all citing articles on Scopus
View full text